Research programme: melanocortin-4 receptor agonists - Eli LillyAlternative Names: MC4R agonists
Latest Information Update: 22 Apr 2009
At a glance
- Originator Eli Lilly
- Class Peptides; Small molecules
- Mechanism of Action Melanocortin type 4 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Obesity